Biotechnology News

August 12, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--bluebird bio, Inc. (Nasdaq: BLUE), a clinical-stage company committed to developing potentially transformative gene therapies for severe genetic and orphan diseases, today reported financial results and...

August 12, 2014

CHICAGO--(BUSINESS WIRE)--Governor Pat Quinn, Mayor Rahm Emanuel, ChicagoNEXT Chairman J.B. Pritzker and the founders of MATTER opened applications for the new health science technology hub.

August 12, 2014

PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Research Reports Fiscal 2014 Third Quarter Financial Results and Provides Update on the Phase 2a study ARC-520 for the treatment of chronic hepatitis b infection

August 12, 2014

SAN DIEGO--(BUSINESS WIRE)--Ignyta, Inc. (Nasdaq: RXDX), an oncology precision medicine biotechnology company, today announced company highlights and financial results for the second quarter ended June 30, 2014. “Since the beginning of the second...

August 12, 2014

SAN DIEGO--(BUSINESS WIRE)--Cytori announces that 6 month outcomes from a 12 patient independent investigator-initiated study using Cytori Cell Therapy to treat scleroderma have been published in the Annals of Rheumatic Disease.

August 12, 2014

CARLSBAD, Calif. & NEW YORK & FRANKFURT, Germany--(BUSINESS WIRE)--The twentieth annual BIO-Europe® international partnering conference will take place November 3–5 in Frankfurt, Germany, at the Portalhaus Messe Frankfurt conference...

August 12, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Eutropics, Inc, (Cambridge, MA) and Tolero Pharmaceuticals, Inc, (Lehi, UT) announced today that clinical study results demonstrating a predictive biomarker for Chronic Lymphocytic Leukemia (CLL) patient...

August 12, 2014

TORONTO & CHICAGO--(BUSINESS WIRE)--Please replace the release with the following corrected version due to multiple revisions. The corrected release reads: RUSH UNIVERSITY MEDICAL CENTER SELLS AMPYRA® ROYALTY RIGHTS TO DRI CAPITAL MANAGED...

August 12, 2014

MONTREAL--(BUSINESS WIRE)--Thrasos appoints two new board members, Gaétan Gravel and Joe Zakrzewski.

August 12, 2014

BOTHELL, Wash.--(BUSINESS WIRE)--Seattle Genetics, Inc. (NASDAQ:SGEN) today announced the initiation of a phase 1 clinical trial evaluating SGN-CD70A for CD70-positive relapsed or refractory non-Hodgkin lymphoma (NHL) and metastatic renal cell...

August 12, 2014

SAN DIEGO--(BUSINESS WIRE)--Taxus Cardium Pharmaceuticals Group Inc. (OTCQB:CRXM) and its Cardium Therapeutics operating unit today presented highlights of financial results for the second quarter ended June 30, 2014.

August 12, 2014

ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE MKT: BTX) today announced that it has received notice from the FDA’s Center for Devices and Radiologic Health that Premvia™ has been cleared for marketing as a Class II medical device. Premvia...

August 12, 2014

PARIS--(BUSINESS WIRE)--ScreenCell announces the first preliminary report on the use of their devices to capture and characterize Circulating Tumor Cells from Colorectal Cancer patients. keywords: single-cell sequencing.

August 12, 2014

ANN ARBOR, Mich.--(BUSINESS WIRE)--Esperion Therapeutics, Inc. (NASDAQ:ESPR) a clinical-stage biopharmaceutical company focused on developing and commercializing first-in-class, oral, low-density lipoprotein cholesterol (LDL-cholesterol) lowering...

August 12, 2014

SAN DIEGO--(BUSINESS WIRE)--bioTheranostics, Inc., announced an important update to its bioT3 Metastatic Cancer Solution, a genomic testing platform that provides personalized diagnostic information and therapeutic guidance

August 12, 2014

ANN ARBOR, Mich. & WATERTOWN, Mass.--(BUSINESS WIRE)--FORMA Therapeutics and Paradigm have entered into a collaboration to optimize FORMA's therapeutic drug candidates for patients and enable a more individualized, targeted approach to drug...

August 12, 2014

ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE MKT: BTX) today reported financial results for the first quarter ended June 30, 2014 and highlighted recent corporate accomplishments. “We are pleased with our success to date in building...

August 12, 2014

CHICAGO--(BUSINESS WIRE)--Huron Consulting Group Launches Clinical Trial Data Analytics and Visualization Service

August 12, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Idera Pharmaceuticals, Inc. (NASDAQ: IDRA), a clinical stage biopharmaceutical company developing nucleic acid therapeutics for rare diseases, today reported financial and operational results for the quarter...

August 12, 2014

LEXINGTON, Mass.--(BUSINESS WIRE)--Concert reports second quarter 2014 financial results and provides pipeline update.

August 12, 2014

BLOOMINGTON, Minn. & IRVINE, Calif.--(BUSINESS WIRE)--DevicePharm, one of the nation's leading medical marketing strategy and integrated marking communications firms, announces the opening of a new office in the Minneapolis-St. Paul, MN...

August 12, 2014

KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--Trevena, Inc. (NASDAQ: TRVN), a clinical stage biopharmaceutical company focused on the discovery and development of G protein coupled receptor (GPCR) biased ligands, today announced financial results for...

August 12, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Acceleron Pharma (NASDAQ: XLRN) today provided a corporate update and reported financial results for the second quarter ended June 30, 2014.

August 12, 2014

NEW YORK--(BUSINESS WIRE)--Retrophin, Inc. (NASDAQ:RTRX) today reported its financial results for the quarter ended June 30, 2014. “We are pleased with our operational and strategic advancements in the second quarter,” said Martin Shkreli,...

August 12, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Foundation Medicine, Inc. (NASDAQ:FMI) today announced that Jason Ryan, senior vice president finance, is scheduled to present at the Wedbush 2014 Life Sciences Conference on Wednesday, August 13, 2014, at 12:45...

August 12, 2014

REGENSBURG, Germany--(BUSINESS WIRE)--Boehringer Ingelheim Vetmedica Acquires Licensing Rights for Artilysin® Technology from Lysando AG

August 12, 2014

CAMBRIDGE, England--(BUSINESS WIRE)--Abcam establishes a new direct service for Australia and New Zealand. The new service will offer researchers improved delivery times and direct technical support.

August 12, 2014

ZHANGJIAJIE, China--(BUSINESS WIRE)--Jinchi Biotech Ltd. (JBL) 2014 Semi–Annual Marketing Conference was held in Changsha Headquarter on July 28, 2014, attended by Mr. Haibo Zhang - Chairman, Mr. Jing Cai - CEO, Ms. Shujun Zhou - CFO, and all the...

August 12, 2014

GÖTEBORG, Sweden.--(BUSINESS WIRE)--Cortendo AB (OSE:CORT) today announced that the first patient has been enrolled into the Phase 3 SONICS trial, i.e., “Study Of NormoCort In Cushing’s Syndrome.” The patient was enrolled by one of the trial’s...

August 12, 2014

OXFORD, England--(BUSINESS WIRE)--Oxford Nanopore Technologies Ltd, the UK-based technology company specialising in nanopore-based electronic molecular analysis systems, has raised £35 million ($59 million) in new funding through a private...

August 11, 2014

NEW YORK--(BUSINESS WIRE)--Synergy Pharmaceuticals Reports Second Quarter and First Half 2014 Financial Results

August 11, 2014

MIAMI--(BUSINESS WIRE)--OPKO Health, Inc. (NYSE:OPK), a multi-national biopharmaceutical and diagnostics company, today reported operating and financial results for its second quarter ended June 30, 2014. Business Highlights Rayaldee Meets...

August 11, 2014

RAMSEY, N.J.--(BUSINESS WIRE)--ADMA Biologics, Inc. (OTCQB:ADMA), a late-stage biopharmaceutical company that develops, manufactures, and intends to market specialty plasma-based biologics for the treatment and prevention of certain infectious...

August 11, 2014

BRIDGEWATER, N.J.--(BUSINESS WIRE)--Insmed Incorporated (Nasdaq:INSM) announced today that it has commenced an underwritten public offering of $80 million of its common stock. All of the shares of common stock in the offering are to be sold by...

August 11, 2014

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--NephroGenex, Inc. (Nasdaq:NRX), a pharmaceutical company focused on the development of therapeutics to treat kidney disease, today reported financial results and business highlights for the second...

August 11, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--AVEO Oncology (NASDAQ:AVEO) today reported its second quarter 2014 financial results and provided an update on its progress toward achieving its strategic plan. “Our strategy for building value remains focused...

August 11, 2014

LOS ANGELES--(BUSINESS WIRE)--Puma Biotechnology (NYSE: PBYI) released its financial results for the quarter and year to date ended June 30, 2014.

August 11, 2014

CARLSBAD, Calif.--(BUSINESS WIRE)--GenMark Diagnostics, Inc. (Nasdaq:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today reported financial results for the quarter ended June 30, 2014. As previously...

August 11, 2014

SAN DIEGO--(BUSINESS WIRE)--Cytori Therapeutics (NASDAQ: CYTX) today reports its second quarter 2014 financial results and provides updates on clinical development and commercialization activities.

August 11, 2014

SAN DIEGO--(BUSINESS WIRE)--Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced today that it intends to offer, subject to market conditions and other factors, $225 million aggregate principal amount of convertible senior notes due 2019...

August 11, 2014

RALEIGH, N.C.--(BUSINESS WIRE)--Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced the topline results from the analysis of the microbiome, culture and susceptibility, and two key secondary efficacy endpoints from data collected in TARGET...

August 11, 2014

SARATOGA, Calif. & FRANKFURT, Germany--(BUSINESS WIRE)--The Myelin Repair Foundation (MRF) and Frankfurt-based Hertie Foundation have entered into a long-term partnership to advance the development of myelin repair therapeutics for MS into...

August 11, 2014

IRVINE, Calif.--(BUSINESS WIRE)--Allergan, Inc. (NYSE: AGN) (“Allergan” or the “Company”) today announced that it received a request for additional information (a “Second Request”) under the Hart-Scott-Rodino Act from the U.S. Federal Trade...

August 11, 2014

SEATTLE--(BUSINESS WIRE)--TapImmune, Inc. (the “Company”), (OTCQB:TPIV), today announced that it has entered into a definitive agreement with an institutional investor for a registered direct placement of $2,000,000 of common stock at a price of...

August 11, 2014

EMERYVILLE, Calif.--(BUSINESS WIRE)--Responding to the U.S. Food & Drug Administration's (FDA) warning that tattoo inks can cause infections, Emeryville Pharmaceutical Services, a provider of chemistry and microbiology services, reminds...

August 11, 2014

DENVER--(BUSINESS WIRE)--Corgenix and Viral Hemorrhagic Fever Consortium partners start work on NIH grant to finalize Ebola rapid diagnostic test kit development.